Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

398.00p
   
  • Change Today:
    -10.50p
  • 52 Week High: 445.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 105.36m
  • Volume: 91,279
  • Market Cap: £419.33m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

Oxford Biomedica still expecting small loss after solid first half

By Josh White

Date: Thursday 08 Aug 2024

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation Oxford Biomedica reported a strong first-half trading performance in an update on Thursday, with revenue expected to reach £50m.

Oxford Biomedica appoints new finance chief

By Josh White

Date: Wednesday 17 Jul 2024

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica announced the appointment of Lucinda 'Lucy' Crabtree as its new chief financial officer and a member of the board on Wednesday.

Oxford Biomedica confident as it moves away from... 29-Apr-2024 ShareCast
Oxford Biomedica shares rise on post-acquisition... 05-Mar-2024 ShareCast
Director dealings: TUI, Oxford Biomedica board m... 27-Sep-2023 ShareCast
Liberum cuts target price for Oxford Biomedica, ... 28-Nov-2022 ShareCast
Oxford Biomedica taps Frank Mathias as its new CEO 22-Nov-2022 ShareCast
Oxford Biomedica swings to loss as Covid vaccine... 15-Sep-2022 ShareCast
Oxford Biomedica inks LSA with new US biotech pa... 07-Sep-2022 ShareCast
Oxford Biomedica inks LSA with US biotech firm, ... 26-Jul-2022 ShareCast
Oxford Biomedica signs new Covid vaccine deal wi... 01-Jul-2022 ShareCast
Oxford Biomedica sees FDA lift clinical hold on ... 14-Jun-2022 ShareCast
Oxford Biomedica posts good growth, notes pause ... 20-Apr-2022 ShareCast
Oxford Biomedica's Parkinson's licensee pulls out 01-Feb-2022 ShareCast
Oxford Biomedica creates venture with Homology, ... 28-Jan-2022 ShareCast
Oxford Biomedica CEO John Dawson to step down 17-Jan-2022 ShareCast
Oxford Biomedica signs licence, supply deal with... 05-Jan-2022 ShareCast
Oxford Biomedica strikes new license and supply ... 13-Dec-2021 ShareCast
Boehringer Ingelheim licenses Oxford Biomedica's... 19-Oct-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 398.00p
Change Today -10.50p
% Change -2.57 %
52 Week High 445.00
52 Week Low 166.80
Volume 91,279
Shares Issued 105.36m
Market Cap £419.33m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.96% below the market average31.96% below the market average31.96% below the market average31.96% below the market average31.96% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
88.50% above the market average88.50% above the market average88.50% above the market average88.50% above the market average88.50% above the market average
96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average
Income Not Available
Growth
52.8% below the market average52.8% below the market average52.8% below the market average52.8% below the market average52.8% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 31-Oct-2024

Time Volume / Share Price
16:40 15,468 @ 397.43p
16:35 18,278 @ 398.00p
16:35 7 @ 398.00p
16:35 357 @ 398.00p
16:35 242 @ 398.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page